CommercialCoverageHigh impact
Sodium Hyaluronate
UnitedHealthcare·Orthopedics, Rheumatology, Pain Management +2 more·Medical Benefit Drug Policy
Effective date
Jul 1, 2026
We identified it
Jun 2, 2026
Summary
UnitedHealthcare has revised their Medical Benefit Drug Policy for Sodium Hyaluronate effective July 1, 2026. This policy update affects coverage and billing requirements for hyaluronic acid injections commonly used for joint pain and osteoarthritis treatment.
Action Required
By July 1, 2026: Billing team must review and implement the revised Sodium Hyaluronate policy requirements from UnitedHealthcare's Medical Policy Update Bulletin. Download the complete policy document from the UHC provider portal to identify specific coverage criteria, prior authorization requirements, and documentation standards. Update billing workflows and inform providers of any new requirements for hyaluronic acid injection claims.